Page 261 - IJB-8-4

Akter, et al.
Topologies within Biocompatible Hydrogels. Science, pulmonary-function-tests [Last accessed on 2022 May 15].
364:458–64. 112. Solomon JJ, Heyman B, Ko JP, et al., 2021, CT of Post-Acute
103. Dasgupta Q, Black LD, 2019, A Fresh Slate for 3D Lung Complications of COVID-19. Radiology, 301:E383–95.
Bioprinting. Science, 365:446–7. https://doi.org/10.1148/radiol.2021211396
https://doi.org/10.1126/science.aay0478 113. Pang B, Li H, Liu Q, et al., 2021, CT Quantification of
104. Alvarez-Aquino FG, Shah S, 2021, Lung Transplantation: COVID-19 Pneumonia at Admission Can Predict Progression
Challenges in the COVID-19 Era, a Review of the Literature. to Critical Illness: A Retrospective Multicenter Cohort Study.
Curr Challenges Thorac Surg, 3:29. Front Med, 8:689568.
https://doi.org/10.21037/ccts-20-172 https://doi.org/10.3389/fmed.2021.689568
105. Bery AI, Hachem RR, 2020, Antibody-Mediated Rejection 114. Raghu G, Wilson KC, 2020, COVID-19 Interstitial
after Lung Transplantation. Ann Transl Med, 8:411. Pneumonia: Monitoring the Clinical Course in Survivors.
https://doi.org/10.21037/atm.2019.11.86 Lancet Respir Med, 8:839–42.
106. Sun W, Starly B, Daly AC, et al., 2020, The Bioprinting https://doi.org/10.1016/S2213-2600(20)30349-0
Roadmap. Biofabrication, 12:022002. 115. Humphries SM, Yagihashi K, Huckleberry J, et al., 2017,
https://doi.org/10.1088/1758-5090/ab5158. Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis
107. Kim IG, Park SA, Lee SH, et al., 2020, Transplantation of a of Extent of Fibrosis at Baseline and 15-Month Follow-up.
3D-Printed Tracheal Graft Combined with iPS Cell-Derived Radiology, 285:270–8.
MSCs and Chondrocytes. Sci Rep, 10:4326. https://doi.org/10.1148/radiol.2017161177
https://doi.org/10.1038/s41598-020-61405-4 116. Peng S, Chen J, Zhang W, et al., 2021, The Role of Chest
108. Yasin R, Gouda W, 2020, Chest X-ray Findings Monitoring CT Quantitative Pulmonary Inflammatory Index in the
COVID-19 Disease Course and Severity. Egypt J Radiol Nucl Evaluation of the Course and Treatment Outcome of
Med, 51:193. COVID-19 Pneumonia. Sci Rep, 11:7752.
https://doi.org/10.1186/s43055-020-00296-x https://doi.org/10.1038/s41598-021-87430-5.
109. Daher A, Balfanz P, Cornelissen C, et al., 2020, Follow Up of 117. Zou JN, Sun L, Wang BR, et al., 2021, The Characteristics
Patients with Severe Coronavirus Disease 2019 (COVID-19): and Evolution of Pulmonary Fibrosis in COVID-19 Patients as
Pulmonary and Extrapulmonary Disease Sequelae. Respir Assessed by AI-Assisted Chest HRCT. PLoS One, 16:e0248957.
Med, 174:106197. https://doi.org/10.1371/journal.pone.0248957
https://doi.org/10.1016/j.rmed.2020.106197 118. Xue M, Zhang T, Chen H, et al., 2021, Krebs Von den
110. Zhao YM, Shang YM, Song WB, et al., 2020, Follow-Up Lungen-6 as a Predictive Indicator for the Risk of Secondary
Study of the Pulmonary Function and Related Physiological Pulmonary Fibrosis and its Reversibility in COVID-19
Characteristics of COVID-19 Survivors Three Months After Patients. Int J Biol Sci, 17:1565–73.
Recovery. EClinicalMedicine, 25:100463. 119. Deng K, Fan Q, Yang Y, et al., 2021, Prognostic Roles of
https://doi.org/10.1016/j.eclinm.2020.100463. KL-6 in Disease Severity and Lung Injury in COVID-19
111. Pulmonary Function Tests. Baltimore, Maryland: Johns Patients: A Longitudinal Retrospective Analysis. J Med Virol,
Hopkins Medicine; 2022. Available from: https://www. 93:2505–12.
hopkinsmedicine.org/health/treatment-tests-and-therapies/ https://doi.org/10.1002/jmv.26793

Publisher’s note
Whioce Publishing remains neutral with regard to
jurisdictional claims in published maps and institutional
affiliations.

International Journal of Bioprinting (2022)–Volume 8, Issue 4 253